Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...

The FDA should have more big news for Vertex only a few weeks later. It expects to announce an approval decision on ...

Investing in biotech stocks can be risky, particularly in the clinical stage, since their success often hinges on the results ...

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

The good news is that if you're willing to put in a bit of effort, it's very possible to improve on your process to secure ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

The biotech industry's future appears bright due to advancements in biochemical and pharma technologies, AI integration, ...

Given all these factors, it seems reasonable to assume that Casgevy could grab at least a decent share, perhaps 20% of its ...

Biotech Nuvalent unveiled updates on two experimental cancer medicines over the weekend. Analysts say each could be the best ...

Two biotech companies whose shares could gain significant traction in the months and years ahead are Viking Therapeutics (NASDAQ: VKTX) and Sarepta Therapeutics (NASDAQ: SRPT).